Following major recalls of Chinese-manufactured medication that contained carcinogenic ingredients, lawmakers expressed their alarm, and sometimes disbelief, at the FDA's inability to regulate foreign suppliers at a Tuesday hearing.
"Disagreements aren't labeled as differing opinions. They're labeled as one's knowledge being 'inadequate,'" Alexandria Ocasio-Cortez said of an industry expert who questioned her knowledge of Big Pharma.
Pharmacy benefit managers arose to fulfill a need created by the Medicare Modernization Act. But now these companies are contributing to escalating drug prices, the very opposite of their original purpose.